Enhanced magnetic resonance imaging in multiple sclerosis

Research output: Contribution to journalArticle

Abstract

Gadolinium-enhanced magnetic resonance imaging (MRI) is very sensitive in the detection of active lesions of multiple sclerosis (MS) and has become a valuable tool to monitor the evolution of the disease either natural or modified by treatment. In the past few years, several studies, on the one hand, have assessed several ways to increase the sensitivity of enhanced MRI to disease activity and, on the other, have investigated in vivo the nature and evolution of enhancing lesions using different non-conventional MR techniques to better define the relationship between enhancement and tissue loss in MS. The present review is a summary of these studies whose results are discussed in the context of MS clinical trial planning and monitoring.

Original languageEnglish
Pages (from-to)320-326
Number of pages7
JournalMultiple Sclerosis Journal
Volume6
Issue number5
Publication statusPublished - 2000

Fingerprint

Multiple Sclerosis
Magnetic Resonance Imaging
Gadolinium
Clinical Trials

Keywords

  • Gd-enhancement
  • MRI
  • MS
  • Treatment trials

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Enhanced magnetic resonance imaging in multiple sclerosis. / Filippi, M.

In: Multiple Sclerosis Journal, Vol. 6, No. 5, 2000, p. 320-326.

Research output: Contribution to journalArticle

@article{d12a276444404726a57586ca0bd33ce8,
title = "Enhanced magnetic resonance imaging in multiple sclerosis",
abstract = "Gadolinium-enhanced magnetic resonance imaging (MRI) is very sensitive in the detection of active lesions of multiple sclerosis (MS) and has become a valuable tool to monitor the evolution of the disease either natural or modified by treatment. In the past few years, several studies, on the one hand, have assessed several ways to increase the sensitivity of enhanced MRI to disease activity and, on the other, have investigated in vivo the nature and evolution of enhancing lesions using different non-conventional MR techniques to better define the relationship between enhancement and tissue loss in MS. The present review is a summary of these studies whose results are discussed in the context of MS clinical trial planning and monitoring.",
keywords = "Gd-enhancement, MRI, MS, Treatment trials",
author = "M. Filippi",
year = "2000",
language = "English",
volume = "6",
pages = "320--326",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - Enhanced magnetic resonance imaging in multiple sclerosis

AU - Filippi, M.

PY - 2000

Y1 - 2000

N2 - Gadolinium-enhanced magnetic resonance imaging (MRI) is very sensitive in the detection of active lesions of multiple sclerosis (MS) and has become a valuable tool to monitor the evolution of the disease either natural or modified by treatment. In the past few years, several studies, on the one hand, have assessed several ways to increase the sensitivity of enhanced MRI to disease activity and, on the other, have investigated in vivo the nature and evolution of enhancing lesions using different non-conventional MR techniques to better define the relationship between enhancement and tissue loss in MS. The present review is a summary of these studies whose results are discussed in the context of MS clinical trial planning and monitoring.

AB - Gadolinium-enhanced magnetic resonance imaging (MRI) is very sensitive in the detection of active lesions of multiple sclerosis (MS) and has become a valuable tool to monitor the evolution of the disease either natural or modified by treatment. In the past few years, several studies, on the one hand, have assessed several ways to increase the sensitivity of enhanced MRI to disease activity and, on the other, have investigated in vivo the nature and evolution of enhancing lesions using different non-conventional MR techniques to better define the relationship between enhancement and tissue loss in MS. The present review is a summary of these studies whose results are discussed in the context of MS clinical trial planning and monitoring.

KW - Gd-enhancement

KW - MRI

KW - MS

KW - Treatment trials

UR - http://www.scopus.com/inward/record.url?scp=0033755083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033755083&partnerID=8YFLogxK

M3 - Article

C2 - 11064441

AN - SCOPUS:0033755083

VL - 6

SP - 320

EP - 326

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 5

ER -